Clinically-oriented research in chronic kidney disease care, including screening, disease management, and preparation for dialysis and kidney transplantation.
Patient Information Second opinions, new patient consultations, and follow up visits are welcome. To make most of your visit, please fax records in advance to 212-241-8488. The following should be included, blood and urine tests, kidney biopsy (if applicable) and kidney and bladder ultrasound or other imaging or reports (if applicable). Reviewing the trends in previous blood tests for serum creatinine and/or estimated GFR is particularly useful.
Education
MD, State University of NY at Stony Brook School of Medicine
Residency, Internal Medicine, Johns Hopkins University School of Medicine
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Vassalotti during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Novo Nordisk, Inc.
Sanofi Aventis
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.
Below are financial relationships with industry reported by Dr. Vassalotti during 2024 and/or 2025. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Consulting or Other Professional Services Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership
Novo Nordisk, Inc.
Sanofi Aventis
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.